![Citeline Trialtrove subscriber accessing data of completed clinical trials.](https://www.citeline.com/-/media/citeline/resources/2024/05/completed-clinical-trials-infographic/resource-hero.jpg?la=en&h=528&w=1340&hash=7388ECE35557829E3B5AADC1A05678C6)
![Citeline Trialtrove subscriber accessing data of completed clinical trials.](https://www.citeline.com/-/media/citeline/resources/2024/05/completed-clinical-trials-infographic/resource-hero.jpg?la=en&h=528&w=1340&hash=7388ECE35557829E3B5AADC1A05678C6)
After a year of decline in 2022, completed clinical trials were on the upswing again in 2023. According to Trialtrove, 4,295 industry-sponsored Phase I-Phase III/IV clinical trials either reached completed status or reported primary endpoints during 2023. This is a 10.7% increase over 2022.
Related products
![Professional using a laptop device to access Trialtrove for trial insights and strategy.](https://www.citeline.com/-/media/citeline/product-services/clinical/trialtrove/product-card.jpg?la=en&h=410&w=666&hash=FC0D6A5177402306BAD6867E05FD00E3)
Trialtrove
The go-to resource for informing clinical trial strategy, design and execution
![Healthcare professional monitoring and analyzing R and D trends.](https://www.citeline.com/-/media/citeline/product-services/clinical/pharmaprojects/product-card.jpg?la=en&h=410&w=666&hash=4B226145401134C8FA3F674CB71EDC65)
Pharmaprojects
The industry standard for tracking and analyzing the global drug R&D landscape
![Citeline consulting expert providing actionable insights on feasibility activities.](https://www.citeline.com/-/media/citeline/product-services/clinical/faas/product-card.jpg?la=en&h=410&w=666&hash=2BBBD472D0C4D060763B2BF84AA4302C)
Feasibility as a Service (FaaS)
Tap into our team of dedicated experts and expedite protocol, country and site feasibility activities
Related resources